Related Experiment Video
Updated: Jul 28, 2025

Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease
Published on: September 20, 2018
Recent Advances in Nanozyme-Based Materials for Inflammatory Bowel Disease
Chuyi Liu1, Qi Wang1, Yun-Long Wu1
1Fujian Provincial Key Laboratory of Innovative Drug Target Research and State Key Laboratory of Cellular Stress Biology, School of Pharmaceutical Sciences, Xiamen University, Xiamen, 361102, China.
Nanozyme-based materials show promise for treating inflammatory bowel disease (IBD). This review explores nanozyme design and therapeutic strategies for effective IBD management and future development.
Area of Science:
- Biomedical Engineering
- Materials Science
- Gastroenterology
Background:
- Inflammatory bowel disease (IBD) is a chronic inflammatory condition impacting patient lifestyles and potentially leading to fatal outcomes.
- Recent advancements in understanding IBD pathogenesis have highlighted nanozyme-based materials as a promising therapeutic avenue.
- Enteritis, a form of IBD, presents significant challenges in patient management and treatment.
Purpose of the Study:
- To review recent advancements in nanozyme-based materials for treating enteritis.
- To explore the structural design of nanozyme materials and their therapeutic strategies for IBD.
- To provide guidance for developing novel enzyme-mimetic nanomaterials for effective IBD treatment.
Main Methods:
- Literature review of recent studies on nanozymes in IBD treatment.
- Analysis of nanozyme structural design principles.
- Evaluation of various therapeutic strategies utilizing nanozymes for inflammation moderation.
Main Results:
- Nanozyme-based materials demonstrate significant potential for managing inflammation associated with IBD.
- Specific structural designs and therapeutic strategies are emerging for enhanced nanozyme efficacy.
- The review synthesizes current knowledge on nanozymes for enteritis treatment.
Conclusions:
- Nanozymes offer a novel and efficient approach for the effective treatment of IBD.
- Further research into nanozyme design and application is crucial for optimizing IBD therapy.
- Understanding current restrictions is key to advancing nanozyme-based treatments for IBD.
More Related Videos
07:05Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation
Published on: December 15, 2017
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Related Concept Videos
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Ulcerative Colitis in IBD
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...